• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Synergy Spine Solutions

Synergy Spine Solutions

Restoring Balance to Motion Preservation

  • Synergy Disc
    • Clinical Research
  • Company Overview
    • About Synergy Spine Solutions
    • Clinical Research
    • Patents
    • Publications
    • News
  • Distributors
  • Contact

Synergy Spine Solutions announce partnership with Healthcare International Partners

November 16, 2021 by OrthoCG

Synergy Spine Solutions is pleased to announce it has expanded its presence in Latin America and the Caribbean through the addition of Healthcare International Partners (HIP) as a commercialization partner.

Already successfully established in multiple markets across Europe and Australia, HIP will help expand market share and support commercialization of the industry-leading Synergy Cervical Disc®.

Synergy Spine Solutions marquis technology, the Synergy Cervical Disc® is the only artificial cervical disc that combines cervical alignment and balance with natural motion for patients with degenerative disc disease (DDD) causing radiculopathy and/or myelopathy. 

It not only provides a superior alternative to other artificial cervical discs on the market today, but it also offers a viable and preferred alternative to many patients whose only current option is fusion surgery.

Established in 2009 and headquartered in Miramar, Florida, HIP has subsidiaries in Mexico, Argentina and Colombia and affiliates in all major markets in Latin America.

Synergy Spine Solutions Vice-President (Sales & Marketing) Tim Hein said: “We are excited to partner with HIP to accelerate the growth and adoption of the Synergy Disc in new markets.

“Our visions are closed aligned, and we share common values and principles as businesses. Throughout the pandemic we’ve continued to introduce the Synergy Cervical Disc to new markets, and we look forward to working closely with HIP CEO Margarita Morales-Perez and her team as we move into 2022.”

“We are looking forward to expanding the utilization of the Synergy Cervical Disc into the major markets in Latin America, supported by Tim and his team.” said Margarita Morales-Perez. “Synergy Spine Solutions provides leading edge technology committed to the highest clinical outcomes and our team is very enthusiastic about this collaboration and its impact in the quality of life for the recipient patients.”

The partnership will complement Synergy Spine Solutions’ existing relationships with Ortho Consulting Group, who oversee all aspects of Sales, Marketing, and Distribution of Synergy Disc products in Europe.

About Synergy Spine Solutions Inc. (Synergy Spine Solutions)

Synergy Spine Solutions is a privately held Ontario corporation with an office in Cambridge, Ontario and a wholly owned subsidiary located in Louisville, Colorado. Synergy Spine Solutions was founded by Dr. Neil Duggal, M.D., a Canadian neurosurgeon who has dedicated his neurosurgery practice to advancing the treatment of patients with DDD and myelopathy. 

Synergy Spine Solutions has developed an advancement in artificial cervical disc technology named the Synergy Disc® and has been issued more than 55 patents, which protect its novel design elements and features of alignment and motion restoration. Synergy Spine Solutions has applied a CE mark on the Synergy Disc and has commercialized the technology in select countries in Europe and Australia with over 1,900 implantations to date. For additional information, please visit here.

CAUTION: ­ Investigational device. Limited by United States law to investigational use.

Filed Under: Press Releases

Footer

Synergy Spine Solutions

Phone: +1.647.692.3493
Email: info@synergyspinesolutions.com

United States Office
357 S. McCaslin Blvd, Suite 120
Louisville, CO 80027, USA

Canada Office
100 Pinebush Road,
Cambridge ON N1R 8J8, Canada

  • Publications
  • Patents
  • Company Overview
  • Distributors
  • Synergy Disc
  • Contact

Copyright © 2022 Synergy Spine Solutions Inc. All Right Reserved. · Privacy Policy
USA Investigational Device Statement: Caution: Investigational Device. Limited by United States law to Investigational use.
230-00001 RevA